z-logo
open-access-imgOpen Access
Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8
Author(s) -
Thomas Walle,
Joscha A. Kraske,
Boyu Liao,
Bénédicte Lenoir,
Carmen Timke,
Emilia von Bohlen und Halbach,
Florian Tran,
Paul Griebel,
Dorothee Albrecht,
Azaz Ahmed,
Meggy SuarezCarmona,
Alejandro Jiménez-Sánchez,
Tizian Beikert,
Alexandra Tietz-Dahlfuß,
Ayse N. Menevse,
Gabriele Schmidt,
Manuela Brom,
Jens Pahl,
Wiebke Antonopoulos,
Matthias Miller,
Ramon Lopez Perez,
Felix Bestvater,
Nathalia A. Giese,
Philipp Beckhove,
Philip Rosenstiel,
Dirk Jäger,
Oliver Strobel,
Dana Pe’er,
Niels Halama,
Jürgen Debus,
Adelheid Cerwenka,
Peter E. Huber
Publication year - 2022
Publication title -
science advances
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 5.928
H-Index - 146
ISSN - 2375-2548
DOI - 10.1126/sciadv.abh4050
Subject(s) - cancer research , pancreatic cancer , radiation therapy , immune system , adoptive cell transfer , innate immune system , immunology , biology , cancer , immunotherapy , cytotoxic t cell , natural killer cell , cancer cell , medicine , t cell , in vitro , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom